GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Institutional Ownership

Savior Lifetec (ROCO:4167) Institutional Ownership : 4.85% (As of May. 02, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Savior Lifetec's institutional ownership is 4.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Savior Lifetec's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Savior Lifetec's Float Percentage Of Total Shares Outstanding is 0.00%.


Savior Lifetec Institutional Ownership Historical Data

The historical data trend for Savior Lifetec's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec Institutional Ownership Chart

Savior Lifetec Historical Data

The historical data trend for Savior Lifetec can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 4.68 4.76 4.80 4.80 4.83 4.85 4.84 4.85 4.85 4.85

Savior Lifetec Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Savior Lifetec Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines